Publication: The under-reported role of toxic substance exposures in the COVID-19 pandemic.
dc.contributor.author | Kostoff, Ronald N | |
dc.contributor.author | Briggs, Michael B | |
dc.contributor.author | Porter, Alan L | |
dc.contributor.author | Hernández, Antonio F | |
dc.contributor.author | Abdollahi, Mohammad | |
dc.contributor.author | Aschner, Michael | |
dc.contributor.author | Tsatsakis, Aristidis | |
dc.date.accessioned | 2023-02-09T09:38:41Z | |
dc.date.available | 2023-02-09T09:38:41Z | |
dc.date.issued | 2020-08-14 | |
dc.description.abstract | Coronavirus disease 2019 (COVID-19) and previous pandemics have been viewed almost exclusively as virology problems, with toxicology problems mostly being ignored. This perspective is not supported by the evolution of COVID-19, where the impact of real-life exposures to multiple toxic stressors degrading the immune system is followed by the SARS-CoV-2 virus exploiting the degraded immune system to trigger a chain of events ultimately leading to COVID-19. This immune system degradation from multiple toxic stressors (chemical, physical, biological, psychosocial stressors) means that attribution of serious consequences from COVID-19 should be made to the virus-toxic stressors nexus, not to any of the nexus constituents in isolation. The leading toxic stressors (identified in this study as contributing to COVID-19) are pervasive, contributing to myriad chronic diseases as well as immune system degradation. They increase the likelihood for comorbidities and mortality associated with COVID-19. For the short-term, tactical/reactive virology-focused treatments are of higher priority than strategic/proactive toxicology-focused treatments, although both could be implemented in parallel to reinforce each other. However, for long-term pandemic prevention, toxicology-based approaches should be given higher priority than virology-based approaches. Since current COVID-19 treatments globally ignore the toxicology component almost completely, only limited benefits can be expected from these treatments. | |
dc.identifier.doi | 10.1016/j.fct.2020.111687 | |
dc.identifier.essn | 1873-6351 | |
dc.identifier.pmc | PMC7426727 | |
dc.identifier.pmid | 32805343 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7426727/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.fct.2020.111687 | |
dc.identifier.uri | http://hdl.handle.net/10668/16113 | |
dc.journal.title | Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association | |
dc.journal.titleabbreviation | Food Chem Toxicol | |
dc.language.iso | en | |
dc.organization | IBS | |
dc.page.number | 111687 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Review | |
dc.rights.accessRights | open access | |
dc.subject | COVID-19 | |
dc.subject | Contributing factors | |
dc.subject | Immune system | |
dc.subject | Pandemic | |
dc.subject | SARS-CoV-2 | |
dc.subject | Toxic mixture | |
dc.subject.mesh | Betacoronavirus | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Coronavirus Infections | |
dc.subject.mesh | Hazardous Substances | |
dc.subject.mesh | Healthy Lifestyle | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Pneumonia, Viral | |
dc.subject.mesh | Quarantine | |
dc.subject.mesh | SARS-CoV-2 | |
dc.title | The under-reported role of toxic substance exposures in the COVID-19 pandemic. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 145 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1